ADC Therapeutics SA (ADCT) vs BGM Group (BGM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ADC Therapeutics SA (ADCT) has outperformed BGM Group (BGM) over the past year, losing 65.0% versus a loss of 96.6%. Over five years, ADCT leads with a -93.8% price change compared with -98.3% for BGM. ADC Therapeutics SA is the larger company by market cap ($203.0 million vs $133.0 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADCT | BGM |
|---|---|---|
| Share price | $1.59 | $9.96 |
| Market cap | $202.99M | $133.01M |
| 1-day change | +11.97% | +6.07% |
| YTD return | -54.96% | -91.00% |
| 1-year return | -64.98% | -96.64% |
| 5-year return | -93.76% | -98.32% |
| EPS (TTM) | $-0.67 | $-4.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.98 | $303.00 |
| 52-week low | $0.78 | $6.45 |
| Distance from 52-week high | -68.07% | -96.71% |
| Analyst consensus | none | — |
| Avg. price target upside | +109.43% | — |
| Average volume | 1.43M | 6.09K |
| Shares outstanding | 127.67M | 12.69M |
| Employees | 188 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ADCT has outperformed BGM by 31.7 percentage points over the past year.
About ADC Therapeutics SA
ADCT stock →ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.
Health Care · Biotechnology: Pharmaceutical Preparations · 188 employees
About BGM Group
BGM stock →BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments.
Health Care · Biotechnology: Pharmaceutical Preparations
ADCT vs BGM FAQ
Which is bigger, ADC Therapeutics SA or BGM Group?
ADC Therapeutics SA (ADCT) is larger, with a market capitalization of $202.99M compared with $133.01M for BGM Group (BGM).
Which stock has performed better over the past year, ADCT or BGM?
ADCT returned -64.98% over the past 12 months, compared with -96.64% for BGM (price return, excluding dividends). Past performance does not predict future results.
Are ADC Therapeutics SA and BGM Group in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.